2025. Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis and Skin of Color. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s549. DOI:https://doi.org/10.25251/skin.10.supp.549.